OrthoPediatrics Corp. KIDS
32.51 USD +0.86 (+2.72%)
Regular-session close
33.00 +0.49 +1.51%
After hours · Nov 19, 4:00 PM ET
30.76 Day range 32.77
14.42 52-week range 34.53
- YTD
- +83.05%
- 1 year
- +95.61%
News
benzinga.com Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $45 Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $30 to $45.
benzinga.com BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $40 BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $30 to $40.
benzinga.com OrthoPediatrics Announces Full Commercial Launch Of Its VerteGlide Spinal Growth Guidance System VerteGlide further strengthens OrthoPediatrics' comprehensive scoliosis portfolio and reinforces the Company's commitment to developing pediatric-specific solutions for complex spinal deformities. It…
benzinga.com Lake Street Maintains Buy on OrthoPediatrics, Raises Price Target to $38 Lake Street analyst Ben Haynor maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $34 to $38.
benzinga.com Canaccord Genuity Maintains Buy on OrthoPediatrics, Raises Price Target to $30 Canaccord Genuity analyst Caitlin Roberts maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $28 to $30.
benzinga.com Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $28 Truist Securities analyst Ravi Misra maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target from $22 to $28.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pulmonx (NASDAQ:LUNG) stock increased by 33.1% to $2.63 during Wednesday's regular session. The company's market cap stands at $85.0 million. As per the press release, Q3 earnings came out…benzinga.com TD Cowen Maintains Buy on OrthoPediatrics, Raises Price Target to $28 TD Cowen analyst Mathew Blackman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $23 to $28.
benzinga.com Stifel Maintains Buy on OrthoPediatrics, Raises Price Target to $27 Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $24 to $27.
benzinga.com Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $30 Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $25 to $30.
benzinga.com BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $30 BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $29 to $30.
benzinga.com OrthoPediatrics Q3 2026 Earnings Call Transcript OrthoPediatrics (NASDAQ:KIDS) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Neumora Therapeutics (NASDAQ:NMRA) shares rose 11.9% to $0.41 during Tuesday's after-market session. The market value of their outstanding shares is at $73.8 million. Pulmonx (NASDAQ:LUNG)…benzinga.com OrthoPediatrics Raises FY2026 Sales Guidance from $265.000M-$269.000M to $270.000M-$273.000M vs $266.983M Est OrthoPediatrics (NASDAQ:KIDS) raises FY2026 sales outlook from $265.000 million-$269.000 million to $270.000 million-$273.000 million vs $266.983 million estimate.
benzinga.com OrthoPediatrics Q3 Adj. EPS $(0.23) Misses $(0.21) Estimate, Sales $72.661M Beat $68.497M Estimate OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 4.17 percent increase over losses of…
